Publications

Found 747 results
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Park L, Wang G, Moore J, Girouard H, Zhou P, Anrather J, Iadecola C.  2014.  The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction.. Nat Commun. 5:5318.
Park L, Hochrainer K, Hattori Y, Ahn SJi, Anfray A, Wang G, Uekawa K, Seo J, Palfini V, Blanco I et al..  2020.  Tau induces PSD95-neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration.. Nat Neurosci. 23(9):1079-1089.
Parikh NS, Kamel H, Zhang C, Kumar S, Rosenblatt R, Spincemaille P, Gupta A, Cohen DE, de Leon MJ, Gottesman RF et al..  2022.  Association between liver fibrosis and incident dementia in the UK Biobank study.. Eur J Neurol.
Parikh NS, Kamel H, Zhang C, Gupta A, Cohen DE, de Leon MJ, Gottesman RF, Iadecola C.  2022.  Association of liver fibrosis with cognitive test performance and brain imaging parameters in the UK Biobank study.. Alzheimers Dement.
Parikh NS, Kumar S, Rosenblatt R, Zhao C, Cohen DE, Iadecola C, Kamel H.  2020.  Association between Liver Fibrosis and Cognition in a Nationally Representative Sample of Older Adults.. Eur J Neurol.
Parikh NS, Navi BB, Schneider Y, Jesudian A, Kamel H.  2017.  Association Between Cirrhosis and Stroke in a Nationally Representative Cohort.. JAMA Neurol. 74(8):927-932.
Parikh NS, Chatterjee A, Díaz I, Pandya A, Merkler AE, Gialdini G, Kummer BR, Mir SA, Lerario MP, Fink ME et al..  2018.  Modeling the Impact of Interhospital Transfer Network Design on Stroke Outcomes in a Large City.. Stroke. 49(2):370-376.
Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H.  2016.  Stroke Risk and Mortality in Patients With Ventricular Assist Devices.. Stroke. 47(11):2702-2706.
Parikh NS, Kamel H, Navi BB, Iadecola C, Merkler AE, Jesudian A, Dawson J, Falcone GJ, Sheth KN, Roh DJ et al..  2020.  Liver Fibrosis Indices and Outcomes After Primary Intracerebral Hemorrhage.. Stroke. :STROKEAHA119028161.
Parikh NS, Merkler AE, Schneider Y, Navi BB, Kamel H.  2017.  Discharge Disposition After Stroke in Patients With Liver Disease.. Stroke. 48(2):476-478.
Parikh NS, Khazanova D, Moya A, Kaunzner UW, Allen BB, Navi BB.  2016.  Clinical Reasoning: An unusual case of blurry vision in a young woman after ovarian induction.. Neurology. 87(5):e49-53.
Parikh NS, Merkler AE, Iadecola C.  2020.  Inflammation, Autoimmunity, Infection, and Stroke: Epidemiology and Lessons From Therapeutic Intervention.. Stroke. :STROKEAHA119024157.
Parikh NS, Merkler AE, Kummer BR, Kamel H.  2018.  Ischemic Stroke After Emergency Department Discharge for Symptoms of Transient Neurological Attack.. Neurohospitalist. 8(3):135-140.
Parikh NS, Kamel H.  2017.  Response by Parikh and Kamel to Letter Regarding Article, "Stroke Risk and Mortality in Patients With Ventricular Assist Devices".. Stroke. 48(1):e27.
Parikh NS, Wahbeh F, Tapia C, Ianelli M, Liao V, Jaywant A, Kamel H, Kumar S, Iadecola C.  2024.  Cognitive impairment and liver fibrosis in non-alcoholic fatty liver disease.. BMJ Neurol Open. 6(1):e000543.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Parauda SC, Zhang C, Omran SSalehi, Schweitzer AD, Murthy SB, Merkler AE, Navi BB, Iadecola C, Kamel H, Parikh NS.  2022.  Risk of Stroke After Posterior Reversible Encephalopathy Syndrome.. Stroke. :101161STROKEAHA122038673.
Pandya S, Kaunzner UW, Rúa SMHurtado, Nealon N, Perumal J, Vartanian T, Nguyen TD, Gauthier SA.  2020.  Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions.. J Neuroimaging. 30(4):537-543.
Panconesi R, Carvalho MFlores, Eden J, Fazi M, Ansari F, Mancina L, Navari N, Da Silva RXavier Sou, Dondossola D, Borrego LBautista et al..  2023.  Mitochondrial injury during normothermic regional perfusion (NRP) and hypothermic oxygenated perfusion (HOPE) in a rodent model of DCD liver transplantation.. EBioMedicine. 98:104861.
Palomo GM, Granatiero V, Kawamata H, Konrad C, Kim M, Arreguin AJ, Zhao D, Milner TA, Manfredi G.  2018.  Parkin is a disease modifier in the mutant SOD1 mouse model of ALS.. EMBO Mol Med.
Palmer EE, Whitton C, Hashem MO, Clark RD, Ramanathan S, Starr LJ, Velasco D, De Dios JKarl, Singh E, Cormier-Daire V et al..  2021.  CHEDDA syndrome is an underrecognized neurodevelopmental disorder with a highly restricted ATN1 mutation spectrum.. Clin Genet.
Paciaroni M, Kamel H.  2019.  Do the Results of RE-SPECT ESUS Call for a Revision of the Embolic Stroke of Undetermined Source Definition? Stroke. 50(4):1032-1033.
Pacholko AG, Bekar LK.  2023.  Different pharmacokinetics of lithium orotate inform why it is more potent, effective, and less toxic than lithium carbonate in a mouse model of mania.. J Psychiatr Res. 164:192-201.
Pacholko A, Iadecola C.  2024.  Hypertension, Neurodegeneration, and Cognitive Decline.. Hypertension.